Syndax Pharmaceuticals Inc is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and ... Syndax Pharmaceuticals Inc is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.9 | -5.68900126422 | 15.82 | 16.16 | 14.32 | 2331350 | 15.12535175 | CS |
4 | 1.78 | 13.5464231355 | 13.14 | 16.58 | 12.92 | 2450663 | 14.62913843 | CS |
12 | -0.65 | -4.17469492614 | 15.57 | 17.5 | 12.06 | 2320662 | 14.20349152 | CS |
26 | -5 | -25.1004016064 | 19.92 | 22.5 | 12.06 | 1730701 | 15.9050942 | CS |
52 | -6.61 | -30.7013469577 | 21.53 | 25.34 | 12.06 | 1406102 | 18.1608083 | CS |
156 | -0.12 | -0.797872340426 | 15.04 | 29.86 | 11.215 | 1111438 | 18.86823373 | CS |
260 | 5.33 | 55.5787278415 | 9.59 | 29.86 | 6.88 | 906752 | 18.73812614 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions